维普期刊资源整合服务平台（V6.5）

38篇 您的检索式：作者名="LEVKAU B"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	A 18F-radiolabeled analogue of CGS 27023A as a potential agent for assessment of matrix-metallo- proteinase activity in vivo显示文摘	Breyholz H J Wagner S Levkau B	2007	Q J Nucl Med Mol Imaging2007，51，1：	1
2	A 18F-radiolabeled analogue of CGS 27023A as a potential agent for assessment of matrixmetalloproteinase activity in vivo显示文摘	Breyholz HJ Wagner S Levkau B	2007	Q J Nucl Med Mol Imaging2007，51，1：	1
3	Cardiovascular effects of sphingosine-l-phosphate (SIP)显示文摘	Levkau B	2013	Handb Exp Pharmacol2013，216，：	1
4	High-density Lipoprotein Stimulates Myocardial Perfusion in Vivo显示文摘	Levkau B Hermann S Theilmeier G	2004	Circulation2004，110，21：	1
5	Cleavage of β-catenin and plakoglobin and shedding of VE-cadherin during endothelial apoptosis: evidence for a role for caspases and metalloproteinases 显示文摘	Herren B Levkau B Elaine W	1998	Molecular Biology of the Cell1998，9，：	1
6	Decorin mediated signal transduction in endothelial cells:involvement of Akt/protein kinase B in up-regulation of P21^WAF1/CIP1 but not p27^KIP1显示文摘	Schonherr E Levkau B Schaefer L	2001	J Biol Chem2001，276，40：	1
7	Coronary Microembolization: From Bedside to Bench and Back to Bedside显示文摘	Gerd Heusch Petra Kleinbongard Dirk B?se Bodo Levkau Michael Haude Rainer Schulz Raimund Erbel	2009	Circulation2009，，18：	1
8	Suppression of endothelial cell apoptosis by high-density lipoproteins (HDL) and HDL-associated lysosphingolipids显示文摘	Nofer JR Levkau B Wolinska I	2001	J Biol Chem2001，276，34：	1
9	Sphingosine-l-phosphate as a mediator of high-density lipoprotein effects in cardiovascularprotection显示文摘	Sattler K Levkau B	2009	Cardiovasc Res2009，82，2：	1
10	Suppression of endothelial cell apoptosis by high density lipoprotein (HDL) and HDL- associated lysosphingolipids 显示文摘	Nofer JR Levkau B Wolinska I	2001	J Biol Chem2001，276，34：	1
11	Survivin signalling in the heart显示文摘	Levkau B	2011	J Mol Cell Cardiol2011，50，1：	1
12	Suppression of endothelial cell apoptosis by high density lipoproteins (HDL) and HDL-associated lysosphingolipids显示文摘	Nofer JR Levkau B Wolinska I	2001	J Biol Chem2001，276，34：	1
13	A 18F- radiolabeled analogue of CGS 27023A as a potential agent for assessment of matrix-metalloproteinase activity in vivo 显示文摘	Breyholz I-IJ Wagner S Levkau B	2007	Q J Nucl Med Mol Imaging2007，51，1：	1
14	Reduction of hypoxia - inducible heme oxygenase - 1 in the myocardium after left ventricular mechanical support显示文摘	Grabellus F Schmid C Levkau B	2002	J Pathol2002，197，2：	1
15	Vascular endothelial growth factor protects cultured rat hippocampal neurons against hypoxic injury via an antiexcitotoxic, caspase-independent mechanism显示文摘	Svensson B Peters M Konig HG Poppe M Levkau B Rothermundt M	2002	J Cereb Blood Flow Metab2002，22，10：	1
16	Cleavage of p21 Cip1/Waf 1 and p27 Kipl mediates apoptosis in endothelial cells through activation of Cdk2: role of a caspase cascade 显示文摘	Levkau B Koyama H Raines EW	1998	Mol Cell1998，1，：	1
17	Sphingosine-l-phosphate as a mediator of high-density lipoprotein effects in cardiovascular protection 显示文摘	Sattler K Levkau B	2009	Cardiovasc Res2009，82，：	1
18	Retroviral over- expression of decorin differentially affects the response of arterial smooth muscle cells to growth factors 显示文摘	Fischer JW Kinsella MG Levkau B	2001	Arterio- scler Thromb Vasc Biol2001，21，5：	1
19	Reversible activation of nuclear factor-κB in human end-stage heart failure after left ventricular mechanical support显示文摘	Levkau B Sokoll A	2002	Cardiovasc Res2002，53，1：	1
20	Immunomodulator FTY720 induces eNOS-dependent arterial vasodilatation via the lysophospholipid receptor S1P3 显示文摘	TOLLE M LEVKAU B KEUL P	2005	Circ Res2005，96，8：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示